Guardant Health Nears Buy Point As Sales Outlook Brightens

Guardant Health (GH) stock reflects how the company holds a unique place among medical services providers. Its offerings stretch across the cancer continuum, ranging from early diagnostics to detecting residual cancer and helping doctors select patients for advanced cancer treatment. The company has also made its mark with its cancer screening capabilities through a simple blood test. Shares broke out…